步长制药：山东丹红拟与山东中医药大学附属医院签署技术转让合同 1500万元

Group 1 - The company, Buchang Pharmaceutical, announced that its subsidiary, Shandong Danhong, plans to sign a technology transfer (development) contract with Shandong University of Traditional Chinese Medicine Affiliated Hospital for a total price of 15 million RMB [1] - The contract involves the transfer of the technical ownership of a traditional Chinese medicine formula aimed at optimizing menstrual regulation, which is intended to enrich the product development pipeline [1] - The ultimate goal of this transaction is to achieve industrial-scale production of the new drug [1] Group 2 - This transaction does not constitute a related party transaction and does not qualify as a major asset restructuring [1]